Ginkgo Bioworks Acquires Reverie Labs Assets in Groundbreaking Biotech and AI Integration Deal
In a groundbreaking move on February 28, 2024, Ginkgo Bioworks secured a deal to acquire essential assets from Reverie Labs. ...
© 2024 Stocks Today
Tag: DNA
Ginkgo Bioworks Awards 782 Million in Restricted Stock Units to Acquired Company Employees
On February 28, 2024, Ginkgo Bioworks awarded a total of $7.82 million in restricted stock units to twelve employees from ...
Ginkgo Bioworks Acquires Patch Biosciences Investing in AI Technology and Talent
On February 28, 2024, Ginkgo Bioworks finalized the acquisition of Patch Biosciences, a pioneer in AI platform development for sequence ...
Ginkgo Bioworks Acquires Proof Diagnostics Advancing Genetic Medicine Through Innovative Technologies
Ginkgo Bioworks has recently completed the acquisition of Proof Diagnostics, a renowned company specializing in cutting-edge genome engineering tools for ...
Goldman Sachs Analyst Downgrades Ginkgo Bioworks Holdings to Sell
As of January 22, 2024, Matthew Sykes, an analyst at Goldman Sachs, has expressed his pessimistic view on Ginkgo Bioworks ...
Ginkgo Bioworks on Track to Achieve Projected Program and Revenue Goals for 2023
Ginkgo Bioworks is on track to achieve its projected program and revenue goals for the year 2023. The company anticipates ...
Don't Miss It
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Unlocking the Future: The Rise of Open-Source FPGA Development Tools
-
The Future of Secure Communications: How Quantum-Resistant Encryption is Revolutionizing Wireless Technology
-
Office Real Estate Investment Trusts REITs WellPositioned for ReturntoWork Trend
-
RTW Investments LP Reduces Stake in Illumina, Inc. (NASDAQ:ILMN) as Company Exceeds Earnings Expectations and Reports Revenue Growth